Rapport's Stock Market Debut Reaps $154M as Novel Epilepsy Med Heads for Mid-Stage Test

Card image cap

Rapport's Stock Market Debut Reaps $154M as Novel Epilepsy Med Heads for Mid-Stage Test
medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Boston , Massachusetts , United States , , Goldman Sachs , Nasdaq , Johnson , Rapport Therapeutics , Third Rock Ventures , Johnson Innovation , Venture Partners , Sofinnova Ventures ,

vimarsana.com © 2020. All Rights Reserved.